You are here

Prices & Quotes - UK Markets - Smith & Nephew (SN.)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 1,545.50p
Change Today:
-0.50p
Market Cap:
13,586m
Sector:
Health Care Equipment & Services

Smith & Nephew slashes costs after first-half market slump

By Josh White

Date: Wednesday 29 Jul 2020

LONDON (ShareCast) - (Sharecast News) - Smith & Nephew reported an 18.7% fall in revenue in its first half on Wednesday, to $2.035bn (1.57bn), as it swung to an operating loss of $5m, from a profit of $419m a year earlier.
The FTSE 100 medical devices maker said its operating loss margin was a negative 0.2% for the half-year ended 27 June, compared to a 16.8% operating profit margin in the equivalent period of 2019.

Cash generated from operations stood at $125m for the period, down from $543m year-on-year, while earnings per share slid to 11.5 US cents, from 35.3 cents 12 months prior.

Smith & Nephew said trading was in line with its 1 July update, as the business was impacted by government-led Covid-19 restrictions, although performance did improve in the second quarter as elective surgeries restarted, with underlying revenue declines of around 47% in April, 27% in May, and 12% in June.

By the end of the second quarter, elective procedures had resumed across the United States and in most European countries, while China also returned to growth for the second quarter.

The firm said the fall in its operating and trading profit margin was in line with previous announcements, explaining that the Covid-19 impact was reflected in lower gross margins, including from an increase in provisions and factory underutilisation, and negative leverage from fixed selling, general and administrative costs.

Discretionary cost saving measures of around $150m were delivered in the first half, out of its programme to deliver up to $200m in 2020.

Smith & Nephew did report that its recently-launched products were performing "strongly", including the 'OR3O' Dual Mobility Hip System' and 'EVOS in Trauma'.

Investment in research and development was maintained, with "significant" new product introductions, including a new robotics platform.

The board confirmed an interim dividend of 14.4 cents would be paid, in line with last year, adding that the company had a "strong" balance sheet and "good" liquidity, with net debt excluding lease liabilities of $2.1bn, weighing against $3.4bn of committed facilities.

Its 2020 guidance remained withdrawn due to continuing uncertainty around the impact of Covid-19.

"We have continued to serve our customers throughout, and were ready as lockdown restrictions eased, delivering an improving performance across the second quarter," said chief executive officer Roland Diggelmann.

"At the same time, we have taken measures to ensure the Group emerges from this crisis as strongly as possible."

Diggelmann said those actions included maintaining its research and development investment, launching new products, protecting jobs, and managing its cost base.

"There remain many uncertainties as countries continue to battle Covid-19, but with our unique portfolio, proven strategy, strong balance sheet and motivated workforce we are ready to take advantage as markets recover."

At 0816 BST, shares in Smith & Nephew were down 4.2% at 1,561.5p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Smith & Nephew Market Data

Currency UK Pounds
Price 1,545.50p
Change Today -0.50p
52 Week High 1,674.00p
52 Week Low 1,336.50p
Volume 239,212
Shares Issued 879.10m
Market Cap 13,586m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector
Price Trend
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Income
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Growth
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. empty sector
  4. empty sector
  5. empty sector
PEG
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
Dividend Yield
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
EPS Growth
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Operating Margin
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 6
Sell 0
Strong Sell 2
Total 16
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith & Nephew Dividends

  Latest Previous
  Final Interim
Ex-Div 01-Apr-21 01-Oct-20
Paid 12-May-21 28-Oct-20
Amount 23.10¢ 14.40¢

Trades for 14-Jun-2021

Time Volume / Share Price
13:28 79 @ 1,545.50p
13:28 101 @ 1,545.50p
13:27 211 @ 1,545.50p
13:27 50 @ 1,545.50p
13:27 100 @ 1,545.50p

Smith & Nephew Key Personnel

Chair Roberto Quarta
CEO Roland Diggelmann